NCT02184078View on ClinicalTrials.gov

Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

December 31, 1998

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

DRUG

Rifabutin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184078 - Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients | Biotech Hunter | Biotech Hunter